One relatively safe bet about how Pfizer's lineup will look different five years from now is that the company will be a ...

Now, it’s worth noting Stock Advisor's total average return is 1,039% — a market-crushing outperformance compared to 182% for ...

On July 25, Leads Biolabs made its official debut on the Hong Kong Stock Exchange. Its shares surged as much as 117% intraday ...

The antibody discovery market is expanding, driven by the increasing incidence of chronic conditions such as cancer, diabetes, and cardiovascular and ...

Bengaluru: British drugmaker GSK expects annual sales and profit to be towards the top of its forecast range, after ...

Cancer clinical trials in the UK are at a critical juncture. They face significant systemic pressures within the NHS and regulatory pathways that threaten efficiency and timeliness. Both commercial ...

The global drug discovery platforms market size is calculated at USD 211.26 million in 2025 and is expected to reach around ...